REGENEREX PHARMA, INC (RGPX) Operating cash flow 2013–2024
REGENEREX PHARMA, INC (RGPX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.6MFY2024 · since FY2013: -$71,641 → -$1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$1.6M | -255.2% |
| FY2023 | -$457,548 | -500.7% |
| FY2022 | -$76,164 | -8.9% |
| FY2021 | -$69,922 | -11.6% |
| FY2020 | -$62,652 | +78.5% |
| FY2019 | -$291,179 | -718.8% |
| FY2018 | $47,059 | +30.3% |
| FY2017 | $36,122 | +1303.9% |
| FY2016 | $2,573 | — |
| FY2013 | -$71,641 | — |
Source: SEC XBRL filings · For reference only · Not investment advice